Quotes for Respiratorius AB
Right Now
- +/-
- %
- 0,00%
- Latest
- High
- Low
- Volume
- 0
- Turnover (SEK)
- 0
- Market Value (MSEK)
- 24,7
- Time (Latest trade)
Board
CEO
- Johan Drott
Chairperson of the Board
- Karin Wehlin
Board
- Johan Drott
- Kristina Drott
- Mia Lundblad
Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer, and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.
CEO
Chairperson of the Board
Board
Name | Capital % | Votes % | Date |
---|---|---|---|
Avanza Pension | 8,57 | 8,57 | 2024-09-26 |
Valcuria Holding AB | 3,61 | 3,61 | 2024-09-26 |
Hans Mandahl | 1,96 | 1,96 | 2024-09-26 |
Fenja Capital Partners A/S | 1,84 | 1,84 | 2024-09-26 |
Hartmut Wiese | 1,45 | 1,45 | 2024-09-26 |
Göran Lennart Rehn | 1,37 | 1,37 | 2024-09-26 |
Nicholas Peebo | 1,10 | 1,10 | 2024-09-26 |
Hans Harvig | 0,99 | 0,99 | 2024-09-26 |
Mattias Nilsson | 0,95 | 0,95 | 2024-09-26 |
Ulf Stahlin | 0,94 | 0,94 | 2024-09-26 |
2025-02-11 Bokslutskommuniké 2024